EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant Mycobacterium avium complex infection

Jiyun Park iD, Sangwon Choi iD, Yae Rin Jeon, Lee-Han Kim iD, Ju Mi Lee iD, Sung Jae Shin iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01511-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Jiyun Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Institute for Immunology and Immunological Disease, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei Un…. Hauptthemen laut MEDLINE: Mycobacterium avium Complex, Drug Resistance, Bacterial, Clofazimine, Antitubercular Agents. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Mycobacterium avium complex (MAC) is the primary cause of pulmonary disease (PD) among nontuberculous mycobacteria, presenting a significant treatment challenge on a global scale. A long-term (≥12 months) three-drug regimen, typically including a macrolide, such as clarithromycin (CLR) or azithromycin, along with rifampicin and ethambutol, is recommended. However, many patients fail to respond adequately to therapy, and some eventually develop macrolide resistance, making the disease even more difficult to treat. This highlights the urgent need for improved therapeutic strategies. Here, we investigated the efficacy of clofazimine (CFZ) and bedaquiline (BDQ), both repurposed from multidrug-resistant tuberculosis therapy, against macrolide-resistant MAC. In macrophage infection assays, both CFZ and BDQ showed significant intracellular inhibitory activity against macrolide-resistant clinical isolates, with CFZ generally exhibiting stronger effects. In a chronic murine model of MAC-caused progressive PD, substitution of CLR with CFZ and BDQ in the treatment regimen led to marked reductions in bacterial loads in both lung and spleen compared with the standard regimen, achieving up to 0.86 log₁₀ CFU reduction in lung and 2.17 log₁₀ CFU in spleen tissues. These findings demonstrate that CFZ and BDQ retain potent activity against macrolide-resistant MAC and highlight their potential as promising components of alternative treatment regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium avium ComplexDrug Resistance, BacterialClofazimineAntitubercular AgentsMycobacterium avium-intracellulare InfectionMicrobial Sensitivity TestsFemaleAnimalsMiceMice, Inbred BALB CMacrolidesDiarylquinolines

Stichwörter der Autor:innen

Mycobacterium avium complexbedaquilineclofaziminedrug combinationmacrolide-resistancemurine model

Substanzen

ClofaziminebedaquilineAntitubercular AgentsMacrolidesDiarylquinolines

Autor:innen und Institutionen

  • Department of Microbiology, Institute for Immunology and Immunological Disease, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, South Korea.

ORCID-Profile: Jiyun Park, Sangwon Choi, Lee-Han Kim, Ju Mi Lee, Sung Jae Shin

Förderung

  • Korea Health Industry Development Institute
  • National Research Foundation of Korea

Zitieren

APA

Park, J., Choi, S., Jeon, Y. R., Kim, L. H., Lee, J. M., & Shin, S. J. (2026). Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant Mycobacterium avium complex infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01511-25

Vancouver

Park J, Choi S, Jeon YR, Kim LH, Lee JM, Shin SJ. Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant Mycobacterium avium complex infection. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01511-25

BibTeX
@article{Park2026,
  author = {Park, Jiyun and Choi, Sangwon and Jeon, Yae Rin and Kim, Lee-Han and Lee, Ju Mi and Shin, Sung Jae},
  title = {Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant Mycobacterium avium complex infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01511-25}
}
Kostenlos starten →